Lobbying registration dated 2026-03-31
Registrant: Paul Williams
Client: Emergent BioSolutions Canada Inc.
Targeted institutions:
Finance Canada (FIN)
Innovation, Science and Economic Development Canada (ISED)
Indigenous Services Canada (ISC)
National Defence (DND)
Public Health Agency of Canada (PHAC)
Canadian Centre for Occupational Health and Safety (CCOHS)
Health Canada (HC)
Government funding received:
Lobbying activity details:
To increase access to publicly funded nasal naloxone.
To discuss proposal to leverage medical countermeasure (biodefence) manufacturing in Canada as portion of NATO GDP commitment. Explore partnership and investment opportunities to support the growth of the life sciences sector in Manitoba.
To advocate for ongoing funding through for Indigenous groups the Emergency Treatment Fund.